Bioabsorbable Therapeutics Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Bioabsorbable Therapeutics General Information
Description
Developer of absorbable stent to treat vascular disease. The company utilizes novel, proprietary anti-inflammatory polymers to create fully bioabsorbable coatings and stents.
Contact Information
Website
www.bioabsorbabletx.comCorporate Office
- 959 Hamilton Avenue
- Menlo Park, CA 94025
- United States
Corporate Office
- 959 Hamilton Avenue
- Menlo Park, CA 94025
- United States
Bioabsorbable Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 30-Sep-2010 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 13-Mar-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 10-May-2007 | $9M | $9.4M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 07-Feb-2006 | $420K | $420K | Completed | Product Development |
Bioabsorbable Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Bioabsorbable Therapeutics Patents
Bioabsorbable Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2009126244-A2 | Devices, systems, and methods for joining body conduits | Inactive | 07-Apr-2008 | ||
| WO-2009126244-A3 | Devices, systems, and methods for joining body conduits | Inactive | 07-Apr-2008 | ||
| WO-2009089072-A1 | Braided, biodegradable stents and methods | Inactive | 11-Jan-2008 | ||
| CA-2667325-A1 | A drug-release composition having a therapeutic carrier | Inactive | 23-Oct-2006 | ||
| WO-2008051565-A2 | A drug-release composition having a therapeutic carrier | Inactive | 23-Oct-2006 | A61K45/06 |
Bioabsorbable Therapeutics Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioStar Capital | Venture Capital | Minority | ||
| Finistere Ventures | Venture Capital | Minority | ||
| MedFocus | Venture Capital | Minority | ||
| Olympus Business Creation America | Corporate Venture Capital | Minority | ||
| Scotasian Capital | Venture Capital | Minority |
Bioabsorbable Therapeutics FAQs
-
When was Bioabsorbable Therapeutics founded?
Bioabsorbable Therapeutics was founded in 2004.
-
Where is Bioabsorbable Therapeutics headquartered?
Bioabsorbable Therapeutics is headquartered in Menlo Park, CA.
-
What industry is Bioabsorbable Therapeutics in?
Bioabsorbable Therapeutics’s primary industry is Therapeutic Devices.
-
Is Bioabsorbable Therapeutics a private or public company?
Bioabsorbable Therapeutics is a Private company.
-
What is Bioabsorbable Therapeutics’s current revenue?
The current revenue for Bioabsorbable Therapeutics is .
-
How much funding has Bioabsorbable Therapeutics raised over time?
Bioabsorbable Therapeutics has raised $9.8M.
-
Who are Bioabsorbable Therapeutics’s investors?
BioStar Capital, Finistere Ventures, MedFocus, Olympus Business Creation America, and Scotasian Capital are 5 of 9 investors who have invested in Bioabsorbable Therapeutics.
-
When was Bioabsorbable Therapeutics acquired?
Bioabsorbable Therapeutics was acquired on 30-Sep-2010.
-
Who acquired Bioabsorbable Therapeutics?
Bioabsorbable Therapeutics was acquired by Xenogenics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process